Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario'€™s life sciences sector - "Diversity of Members, Unity of Voice".

New Streamlined System for Research Ethics Review Launched in Ontario

Thursday, March 5, 2015

A new streamlined approach for the ethical review and oversight of multi-centre clinical trials in Ontario was launched today by Clinical Trials Ontario (CTO). The CTO Streamlined Research Ethics Review System allows any single CTO Qualified research ethics board in Ontario to provide ethical review and oversight on behalf of multiple research sites involved in a clinical trial. The current approach in Ontario has been to conduct a research ethics review at each and every research institution participating in the same clinical trial.

[ Read more here]

LSO Launches 2015 Sector Report

Wednesday, February 25, 2015

Life Sciences Ontario's 2015 Sector Report provides first evidence-based economic impact data and benchmarks against North American jurisdictions

If you work in the life sciences in Ontario, your wages are approximately 26.5 per cent higher than those of the provincial average. On the other hand, if you're a recent science graduate, you're facing a challenging unemployment rate of 18.9 per cent.

[ Read more here]

Dean On Campus Blog: Building bridges to industry with Paul Lucas

Friday, February 27, 2015

When I became Dean of the Faculty of Health Sciences at Queens and began talking about the idea of building partnerships with industry, I realized that I was entering into a divided world. The pendulum, with respect to industry-academic relationships had swung far to the left; communications were not open, relationships were fractured. I knew that bringing that pendulum back to the centre had to be a goal of mine, and yet I knew I couldnt do it alone.

[ Read more here]

Merck Announces a Contribution of $7.5 Million to the Structural Genomics Consortium (SGC) Toronto

Wednesday, February 4, 2015

TORONTO, February 4, 2015 /CNW/ - At an announcement made earlier today at MaRS Discovery District, Merck, known as MSD outside the United States and Canada, confirmed its commitment to research and innovation by contributing a total of $7.5 million to the Structural Genomics Consortium (SGC) Toronto and its network, thereby becoming a member of the consortium.

The supported projects focus on pre-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in Ontario and around the world, use of the probes will expand the understanding of biology in multiple disease areas, particularly cancer and inflammatory diseases.

[ Read more here]